A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma

Howard Sofen, Kenneth G. Gross, Leonard H. Goldberg, Harry Sharata, Tiffani K. Hamilton, Barbara Egbert, Benjamin Lyons, Jeannie Hou, Ivor Caro

Research output: Contribution to journal › Article › peer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences